Clinical Trials Logo

Clinical Trial Summary

To examine reward processing and cognitive control both with and without the influence of vaporized nicotine in young adults with no history of cigarette use using EEG and fMRI. The goal is to determine whether acute nicotine administration using a Juul device would impact functional correlates of reward and inhibitory control in people who commonly use juul devices.


Clinical Trial Description

Aim 1: To examine reward processing both with and without the influence of vaporized nicotine in young adults with no history of cigarette use using EEG and fMRI. The goal is to determine whether acute nicotine administration using a Juul device would impact functional correlates of distinguishable reward processes (anticipatory and consummatory reward) in young adults who commonly use juul devices. Predictions are that juul use will have an impact on activity in the striatum, resulting in reduced activation in fMRI and smaller amplitudes in event-related potentials (ERP) in response to reward cues and reward feedback. Aim 2: To examine cognitive control both with and without the influence of vaporized nicotine in young adults with no history of cigarette use using EEG and fMRI. The goal is to determine whether acute nicotine administration using a Juul device would impact functional correlates of behavioral inhibition in young adults who commonly use juul devices. Predictions are that juul use will affect the inhibitory circuit, including the anterior cingulate and the dorso-lateral prefrontal cortex, resulting in decreased activation in these regions during fMRI and reductions in the FRN and P300 ERP responses in response to inhibitions and to commission errors. Predictions also include that inhibitory control behavior will be impaired after juul use. Aim 3: To establish feasibility of naturalistic use of vaping devices for nicotine administration and observing the effects in the laboratory. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04901208
Study type Interventional
Source Yale University
Contact
Status Completed
Phase N/A
Start date April 5, 2020
Completion date August 17, 2022

See also
  Status Clinical Trial Phase
Completed NCT05037656 - Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths N/A
Recruiting NCT05454267 - Early Detection of Vaping-related Vascular Diseases
Enrolling by invitation NCT04678245 - Network Intervention to Prevent Vaping N/A
Recruiting NCT06297005 - The Impact of E-cigarettes During Pregnancy on Childhood Health Outcomes Study
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Completed NCT04522362 - Modeling Stress-precipitated Vaping Behavior N/A
Completed NCT04054765 - A Virtual Reality Videogame for E-cigarette Prevention in Teens N/A
Recruiting NCT06291597 - Vaping Adverse Lung and Heart Events Cohort
Active, not recruiting NCT04919590 - Text Message Quit Vaping Intervention for Adolescents N/A
Completed NCT04568395 - Acute Effects of TCIG vs ECIG in PLWH N/A
Completed NCT04707911 - Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents N/A
Withdrawn NCT04340700 - Characterization of the Pharmacodynamic Response to Vaped THC Phase 3
Not yet recruiting NCT06335329 - Point-of-Care Ultrasound (POCUS) Findings and Impact on Vaping N/A
Completed NCT06433466 - Influencer Marketing: a Survey-based Experiment N/A
Active, not recruiting NCT05488743 - Smoking Prevention Program in Poland
Terminated NCT05240027 - To Vape or Not to Vape N/A
Recruiting NCT04661683 - Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol N/A
Completed NCT04450537 - PACE Vape Messaging Study N/A
Active, not recruiting NCT05367492 - Varenicline for Nicotine Vaping Cessation in Adolescents Phase 4
Completed NCT04879225 - Menthol and Mint Experimental Tobacco Marketplace (ETM) Study N/A